A re-staging transurethral resection predicts early progression of superficial bladder cancer

BJU International

Volumn 97, Issue 6, 2006, Pages 1194-1198

  Herr, Harry W ^a   Donat, S Machele ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Progression; Re staging transurethral resection; Superficial bladder tumour

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE METASTASIS; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SUBMUCOSA; SUPERFICIAL CANCER; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CYSTECTOMY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; REOPERATION; RISK FACTORS; URETHRA; URINARY BLADDER NEOPLASMS;

EID: 33745216241     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06145.x     Document Type: Article

References (18)

1. Holmang S, Hedelin H, Anderstrom C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995 153: 1823 7
2. Andius P, Holmang S. Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression. BJU Int 2003 93: 980 4
3. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 2001 165: 1124 30
4. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000 163: 73 8
5. Konety BR, Williams RD. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 2004 94: 18 21
6. Holmang S, Johansson SL. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 2002 167: 1634 7
7. Lee CT, Montie JE, Zhang YX et al. Lymphovascular invasion is an independent predictor of survival in cT1 bladder cancer. J Urol 2005 173: 246, Abstract
8. Goddard JC, Sutton CD, Furness PN, O'Bryne KJ, Kockelbergh RC. Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer. Clin Cancer Res 2003 9: 2583 6
9. Cheng L, Weaver AL, Neumann RM, Scherer BG, Bostwick DG. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal. Cancer 1999 86: 1035 43
10. Hitchings AW, Kumar M, Jordan S, Nargund V, Martin J, Berney DM. Prediction of progression in pTa and pT1 bladder carcinomas with p53, 16 and pRb. Br J Cancer 2004 91: 552 7
11. Blaveri E, Simko JP, Korkola JE et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005 11: 4044 55
12. Montie JE, Bahnson RR, Cohen SM et al. Bladder cancer clinical practice guidelines in oncology. JNCCN 2005 3: 4 34
13. Chang SS, Cookson MS. Radical cystectomy for bladder cancer: the case for early intervention. Urol Clin North Am 2005 32: 147 55
14. Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999 162: 74 6
15. Herr HW. Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 2005 32: 157 64
16. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Conference Committee. Am J Surg Pathol 1998 22: 1435 48
17. Joudi FN, Smith BJ, O'Donnell MA, Konety BR. Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Urology 2003 62: 1083 8
18. Chung D, Hersey K, Fleshner N. Differences between urologists in United States. and Canada in approach to bladder cancer. Urology 2005 65: 919 25